BREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES Trademark

Trademark Overview


On Friday, August 27, 2010, a trademark application was filed for BREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES with the United States Patent and Trademark Office. The USPTO has given the BREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES trademark a serial number of 85117504. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 18, 2022. This trademark is owned by MacroGenics, Inc.. The BREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases

Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
breakthrough biologics, life changing medicines

General Information


Serial Number85117504
Word MarkBREAKTHROUGH BIOLOGICS, LIFE CHANGING MEDICINES
Filing DateFriday, August 27, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 18, 2022
Registration Number4139797
Registration DateTuesday, May 8, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements


Goods and ServicesProduction and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases
Disclaimer with Predetermined Text"BIOLOGICS" AND "MEDICINE"
Goods and ServicesDiscovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 18, 2022
Primary Code035
First Use Anywhere DateMonday, August 3, 2009
First Use In Commerce DateMonday, August 3, 2009

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 18, 2022
Primary Code042
First Use Anywhere DateMonday, August 3, 2009
First Use In Commerce DateMonday, August 3, 2009

Trademark Owner History


Party NameMacroGenics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameMacroGenics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Friday, November 18, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, May 8, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 18, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, May 18, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 18, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 7, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, May 8, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 8, 2012REGISTERED-PRINCIPAL REGISTER
Wednesday, April 4, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 3, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, April 3, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 30, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, March 5, 2012USE AMENDMENT FILED
Thursday, March 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 5, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, September 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 14, 2011ASSIGNED TO LIE
Tuesday, May 31, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 26, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 26, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 24, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 24, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 16, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 16, 2010NON-FINAL ACTION E-MAILED
Thursday, December 16, 2010NON-FINAL ACTION WRITTEN
Friday, December 10, 2010ASSIGNED TO EXAMINER
Wednesday, September 1, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 31, 2010NEW APPLICATION ENTERED IN TRAM